Survey sui Modelli di gestione delle Malattie Rare: uno studio Discrete Choice Experiment (DCE)

Title

Code

SMaRa-DCE

Type

Osservazionale

Start Year

2026

Status

In Corso

Principal Investigator

051-6366519, 051-6366681

luca.sangiorgi@ior.it

Sangiorgi Luca, MD

Director

Rare skeletal disorders

Operational unit that carry out the study

complex unit

Malattie rare scheletriche

Director

Sangiorgi Luca, MD

Go to the details >>

Documents and Videos attachament

Attachment

Informazioni sul trattamento dei dati - prot. SMaRa-DCE

Friday 13 February 2026, 11:02

PG0015282_2025_06_Informativa_Trattamento_Dati__v1 - def.pdf

Attachment

Nulla osta alla conduzione dello studio prot. SMaRa-DCE

Friday 13 February 2026, 11:01

PG0001504_2026_Nulla osta DG_SMaRa-DCE - Sangiorgi.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Survey sui Modelli di gestione delle Malattie Rare: uno studio Discrete Choice Experiment (DCE)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Survey sui Modelli di gestione delle Malattie Rare: uno studio Discrete Choice Experiment (DCE)

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in